Dietary and genetic evolution
The diversity in dietary habits as well as on genetics traits among human beings has been enormous during the evolutive period of the mankind [1] . There are records of the various diets followed by different populations world-wide. Data from the Stone Age (35000-10000 BC) suggest a low fat intake (<22 as en%) and a high protein and carbohydrate consumption (about 40 as en%). The hunters-gatherers lifestyle, which influences the animal or plant food availability sustained humanity for the subsequent 10,000 years, and markedly affected the macronutrient intake (protein 19-35 as en%), carbohydrate 22-40 as en%, fat 28-58 as en%. With advances in agriculture and livestock breeding (10 000 BC to third millennium), the achieved values during the last century were 10-17 as en% for protein, 40-60 as en% for carbohydrate and 20-59 as en% for fat. In most industrialised countries more fat (40-50 en%), especially saturated fats and less carbohydrates (40-45% E) were eaten, which was associated to a relevant reduction of starch consumption. Besides, individuals in high and low income countries have experienced important and rapid changes with regard to diet in the last decades, accompanied by a growing prevalence of chronic diseases, including obesity.
However, since the time when man appeared on earth (about 2.4x10 6 years), only minor changes have occurred in the human genome [2] . In fact, a difference in the gene make up of only about 1.6 % was found between modern man and most developed primates.
In spite of this overall stability of the human genome, a number of minor alterations in gene structures have been observed. Thus, ethnic and racial differences for various traits have long been recognised. Also, some specific genes have been reported recently to be in connection with the risk of developing obesity, type 2 diabetes or cardiovascular disease. For obese individuals, numerous single polymorphisms have been discovered and characterised in the last two decades [2, 3] .
Genetic and dietary influences on obesity at the present time
Obesity as a complex disease associated to an excessive fat deposition, rarely arise from a unique mutation in a single gene, although there is one relevant example. Monogenic obesity is caused by single mutations in the melanocortin 4 receptor (MC4R) which participates in food intake regulation [4, 5] . There are more than 40 functionally relevant MC4R mutations in 2-4% of extremely obese individuals.
Commonly, an obese individual will have inherited minor functional mutations or gene variants in genes coding for key proteins involved in the regulation of body weight [6, 7] . These combined genetic effects account for the biological diversity and in their absence all organisms would respond in a virtually identical manner to the same environmental challenge. Thus, the interaction of functional gene polymorphisms with environmental factors may play a substantial role in the risk of developing obesity.
The research of gene-environment interactions implies that the interplay between genotype and environment deviates from the additive or multiplicative effects of these two factors (Figure 1 ). This outcome could be a result of chance alone, which highlights the importance of confirmatory findings, but an absence of interaction, could also simply reflect the lack of statistical power (i.e. sample size) in the study to detect such an effect [8] . Genotype-environment interactions (G x E) arise when the response of a phenotype (e.g., body weight) to environmental changes (e.g., overfeeding) depends on the individuals genetic background. Most of the genetic epidemiology studies on human obesity have assumed the absence of genotype-environment interactions simply because of the difficulties in assessing such interactive effects in quantitative genetic models.
A working model for the interaction of genetic and environmental factors is presented ( Figure 2 ). A higher obesity risk (represented by a quantitative trait BMI) will arise from the presence of an obesity-related gene variant and environmental influences (high consumption of carbohydrates) for a population carrying a given polymorphism. Indeed, individuals inherited a number of gene variants in key loci, but they make some particular lifestyle choices (e.g. low-fat versus high-fat diets, high versus low levels of physical activity, etc.) affecting weight gain. Thus, while environmental factors may be changed in the short-term, genetic factors can not, but they might interplay. The geneenvironment relationship is a big challenge to be faced for scientist.
Measuring genetic and environmental factors
There are several well-documented environmental variables that influenced body weight gain and increased obesity risk [9] [10] [11] [12] [13] [14] [15] [16] . These variables include excessive calorie intake and sedentary lifestyles. However, these environmental variables are often difficult to quantify with accuracy in free-living individuals. In small intervention studies, it is possible to estimate energy intake and expenditure with a high degree of accuracy, but such experimental trials usually have very little power for genetic studies or for screening gene-environmental interactions. Besides, there is large inter-individual diversity in metabolic responses. Generally in intervention studies over 50% of the subjects show changes in the main direction, a minority of subjects does not exhibit any change, and a few subjects show changes in the opposite direction. This observation clearly indicated that each subject can display both general traits and some particular susceptibility to a given environment (dietary) factor [8] .
Moreover, most environmental factors are assessed by questionnaires and may be under-reported (e.g. food intake) or over-reported in the case of exercise. In regard to food intake, daily food records may be useful, but assessing fat content or fatty acid composition is not straightforward [8] . What is desirable is to have biological markers for environmental factors, like plasma measures of by-products that can be objectively quantified as a marker of dietary compliance.
Environmental risk factors: Diet composition
The content and distribution of the macronutrient intake appears to strongly influence the regulation of food intake and may affect energy utilisation [13, 15] . The ratio fat to carbohydrate is the main factor that easily causes passive energy overconsumption leading to weight gain [16] . The combination of carbohydrate-sweetened beverages intake and an increasingly sedentary lifestyle, which reduces the metabolic demand for fat as fuel, has been associated to an excessive weight gain. Long-term studies are needed to explore the independent effects of dietary sugars (solid or liquid) and glycemic load on body weight control.
There are more epidemiological data associating high-fat consumption with obesity development, although the results appear to be indicative but no conclusive. A controversial question is whether or not high-fat diets versus low-fat diets with the same equivalent total energy contributed to weight gain [10, 11] . In several weight-loss studies prescribing low carbohydrate diets (moderate to high fat content) as compared to low fat diets, there was no major difference in the average weight reduction [17] . In another trials, a more beneficial lipid profile was found in individuals fed on high fat diet [18] . This heterogeneity supports the idea that there are individual differences in the fat responses, which maybe partially explained by genetic susceptibility and genenutrient interactions.
Genetic risk factors
Despite that dietary factors play a significant role in the development of obesity, a number of reports over the last decades have clearly documented a genetic contribution to obesity-related phenotypes as well [2] [3] [4] [5] . Obesity and its related traits represent the archetype of a common complex phenotype. The configuration of multiple genes can range from polygenic (i.e. many genes with a relatively small contribution) to oligogenic (i.e. few genes with large measurable effects often expressed on a residual polygenic background). Indeed, it is this oligogenic architecture that warrants all current efforts to map genes for complex phenotypes [19, 20] .
In this context, quantitative genetic analyses (twins, siblings and family studies) have shown significant hereditability (an individual's chances of being obese are increased when having obese relatives) with estimates generally ranging from 30-70% [4, 6] .
From the late 1980s through the early 1990, segregation analysis was applied in an effort to dissect further the genetic architecture underlying human obesity by attempting to detect the effects of anonymous major genes on obesity related phenotypes. A number of these studies have reported consistent evidence of anonymous major gene effects accounting for as much as 40% of the variation in BMI or fat mass in a variety of populations [6, 20] .
By the early to mid-1990s, researchers began to focus on the goal of identifying the specific genes involved. Initially such effort to identify specific genes influencing complex traits such as those associated with obesity relied on the use of a priori defined candidates genes [3, 19] . regulation and obesity development [2] . Moreover, there are 272 studies in obese humans reporting positive associations with 90 candidate genes [2, 3] . Here a selective number of mutations in genes encoding factors regulating food/energy intake as well as factors related to energy expenditure and adipogenesis is reviewed.
Genetic background and obesity
Body weight regulation and stability depends upon an axis with three interrelated components: food intake, energy expenditure and adipogenesis, although there are still many unknown features concerning fuel homeostasis and energy balance, in which the genetic make-up is involved.
Genes encoding factors regulating food/energy intake
Hypothalamic and brain stem centres are involved in the regulation of food intake and energy balance, but information on the relevant regulatory factors was scarce before the last decade [3, 19] . Insulin remained the only candidate with a key role in body weight regulation for a long time until the discovery of leptin. This cytokine-like peptide mainly expressed by adipocytes is now believed to be a key regulator of fat metabolism and energy intake. Leptin is the product of human homologue of mouse "obese" gene, whose homozygous mutation caused hereditary obesity in mice (monogenic) [20] [21] [22] .
The mechanisms participating in the effects of leptin and other peptides on food intake and body weight regulation are now becoming to be understood. Factors acting at the central nervous system level include: neuropeptide Y, corticotropin releasing hormone, proopiomelanocortin, α-melanocyte stimulating hormone, agouti-related protein, melanin-concentrating hormone, cocaine-and amphetamine regulated transcript and other molecules [3, 20] . Interactions among them involving complex neuronal mechanisms, eventually influence behavior and provide important links with neuroendocrine regulation of other vital functions of the organism.
Studies in humans have failed to find leptin or any other mutant gene to be the unique "obesity gene". Conversely, multifactorial patterns involving the action of numerous polymorphic gene products now look more likely to occur. Evidence is accumulating that most of these genes encoding central peptide factors as well as their receptors (leptin receptors, melanocortin receptors, NPY receptors) are polymorphic [19] . NPY is released from the arcuate hypothalamic nucleus in fasting or hypoglycemia situations and its secretion is inhibited after food intake. The Leu7Pro polymorphism in
the NPY gene appears to be involved in lipid metabolism regulation. It is highly prevalent in Caucasians, but not in Japaneses and this suggests that the role of this polymorphism may vary across different population groups. Common polymorphisms in the genes encoding NPY receptors can present another source of variation in this appetite signalling system [19] .
A number of peptides synthesised along the gastrointestinal tract also affect food intake.
They include ghrelin (orexigenic peptide mainly produced in the stomach), cholecystokinin (produced in the small intestine acting as a short-term satiety signal) and peptide YY3-36 (produced in the colon and suppressing appetite for up to 12 hour).
Exploration of these signalling pathways has started and it is becoming clear that polymorphisms in relevant genes may have important functional consequences. One SNP in the highly polymorphic ghrelin gene was found to be associated with fat accumulation [19] .
Moreover, the identification of relevant genes related to food preferences has just started. Taste 2 receptors (T2Rs) have been shown to function as bitter taste receptor and T1Rs as putative receptor for sweet taste. There is no information on polymorphism in the T1R family genes, while some SNPs in T2R have been reported [19] . Rapid progress has been made in this field to elucidate the genetic mechanism underlying food preferences.
Genes encoding factors involved in energy expenditure
The adaptive thermogenesis in humans is closely related to the active mobilisation of lipids from fat tissues and presents special interest in relation to obesity. Central neural pathways responsible for the food intake and energy expenditure regulation are tightly may alter lipolytic function contributing to fat accumulation. In men, the 27Glu allele has been associated with increased BMI, subcutaneous fat, elevated leptin and triglycerides levels and increased risk for abdominal obesity [27] . In an intervention study, our group has shown that women homozygotes for the 27Glu allele have impaired the exercise-stimulated lipolysis [23] [24] . We also observed an effect modification (interaction) on obesity risk linked to the 27Glu polymorphism by recreational energy expenditure levels. Women carrying of the 27Glu allele and active in their leisure time had a higher BMI compared to non-carriers, being more resistant to lose weight when they were exposed to higher physical activity levels [30] .
The β 3 -adrenergic receptor (ADRB3) protein plays a role in adipocyte metabolism mediating the rate of lipolysis in response to catecholamines. A common polymorphism in this gene, characterised by an amino acid replacement of tryptophan by arginine at position 64 (Trp64Arg), has been identified and may be linked to lower lipolytic activity accounting for lipid accumulation in adipose tissue [3, 19] . In regard to BMI, more than nine studies had shown a statistically significant association between BMI and the Trp64Arg polymorphism in a variety of populations. Moreover, 2 meta-analysis examining the effect of this mutation on BMI have been published for Caucasian populations [3, 26] . One includes 2.447 subjects and the significant BMI difference among carriers and non-carriers of the mutation is 0.30 kg/m 2 . In the second survey on 7399 subjects, the results were not statistically significant.
Clement et al [32] found that morbidly obese subjects with the Arg allele in the ADRB3 gene had a significantly higher weight gain (current weight -weight at 20 years).
Similarly, several studies carried out among Mexican American, Japanese and
Caucasian women have showed that carriers of the Arg allele had a higher BMI and lower reduction in visceral fat after weight-loss [3] . In a Spanish population we found [33] [34] , but their role is still under investigation. Thus, UCP2 and UCP3 appear to be regulators of energy homeostasis, acting as a fatty acid transmembrane transporter in the mitochondria and facilitating protons exchange [3] .
These observations have led to the consideration of UCP´s as candidate genes for obesity, given their function in the regulation of fuel metabolism.
A number of human studies indicated a relationship between UCP´s polymorphisms and exercise efficiency, resting energy expenditure, substrate oxidation, energy metabolism, BMI, leptin, fat accumulation, body weight changes, physical activity and also risk of type 2 diabetes or obesity [33] [34] . Several UCP2 gene variants were described: a G/A mutation in the promoter region -866G/A, a valine for alanine substitution at amino acid 55 in exon 4 (Ala55Val) and a 45 base pair insertion/deletion in the untranslated region of exon 8 [34] . The association between these polymorphisms of the UCP2 and various aspects of obesity has been intensively studied. It seems that the allele G in the promoter region of UCP2 increases obesity risk, while it affords relative protection for type 2 diabetes [3] . Meanwhile the Ala55Val polymorphism has shown to be associated with increased exercise efficiency [3] . However, results concerning the exon 8 insertion allele of the UCP2 gene have been inconsistent. Although no association with obesity was observed in a number of studies conducted in several populations [33] , significant associations between the exon 8 insertion of the UCP2 gene and BMI or fat mass or presence of obesity were found. Thus, in a Spanish sample we also reported a higher obesity risk for carriers of the exon 8 insertion allele of the UCP2 gene after adjusting for lifestyle influences [34] .
There are also several UCP3 gene variants potentially involved in weight gain regulation. In linkage studies, some of them have been related to a higher obesity risk [3] . Specifically, the -55C T polymorphism in the promoter region, which has been associated with an elevated body mass index (BMI), an increased level of adiposity or a greater waist-to-hip ratio [3] . However, other authors have not found any relationship between this polymorphism and a higher risk of obesity or changes in metabolic rate.
Some studies have even reported an inverse correlation with BMI and the presence of -55C T polymorphism [3] . The inconsistencies in some studies may be due to differences in the populations studied, methodological issues and the lack of an adequate consideration of confounding factors (age, gender and lifestyle factors)
affecting gene x nutrient interactions.
Genes encoding factors involved in adipocyte metabolism
The last group of genes acting in connection with the peripheral regulation of energy expenditure encompasses the transcription factors leading to adipogenesis and adipocyte differentiation. The key actors are peroxisome proliferator-activated receptor γ, particularly the adipose specific isoform PPARG2. In a meta-analysis with 19,136 subjects, a positive association between BMI and the Pro12Ala polymorphism of the PPARG2 gene was found [35] . In a Spanish group, the frequency of the Ala allele was similar to other Caucasian populations, but higher in obese subjects (allelic frequency 0.13) compared to controls (0.08) suggesting that this polymorphism was associated with obesity [36] . There is also information on the functional role of PPARG gene variants and some mutants proteins appear to have a reduced activity [3] .
Discrepancies among investigators on the effect of a given polymorphism on obesityphenotypes may be explained by the environmental influences. The lifestyle factors specially those related to diet (macronutrient composition or total energy intake) can interact with the genetics factor and may mask the genotype influences.
Strategies for searching gene-diet interactions in regard to obesity phenotypes
It is possible to investigate gene-diet interactions in human obesity using either intervention or epidemiological observational studies. The objective is to address the influence of each environmental factor in regard to the whole genome or specific gene variants influence.
Four methods can be used to provide evidence for G x E effects in humans when molecular markers are available [2, 9] . The first is to compare the influence of a gene on a given phenotype between populations of different ethnic and cultural backgrounds.
The second method consists of comparing the effect of a gene between subgroups of individuals within the same population, but categorised on the basis of variables that can potentially affect the phenotype under study. In the third method, the response to an environmental stimulus is investigated among individuals with different genotypes at a given gene or marker locus. A fourth method is based on the "variability gene", which contributes to the susceptibility to changes in the environment.
The overfeeding approach represents another type of intervention trial. Thus, Bouchard et al [37] performed studies in monozygotic twins after a long-term standardised overfeeding period (100 days). The volunteers, 12 pairs of identical male twins, were fed with a diet containing 1000 kcal above their baseline measured energy intake, composed of 50% carbohydrates, 35% fat, and 15 % protein. After the overfeeding period the weight gain achieved was 8.1 kg with a 67% of weight gain attributable to fat mass. Interestingly, the within-pair resemblance for changes in body weight and fat mass and other adiposity markers was statistically significant. To dissect the molecular bases of such genotype-overfeeding interaction, 40 candidate gene variants were studied [38] . The major association between body weight gain or subcutaneous fat mass and overfeeding was seen for the Gln27Glu polymorphism of the ADRB2. Surprisingly, non-carriers of the Glu allele were heavier (7 % increase of body weight) and had higher subcutaneous fat gain than Glu carriers [38] .
The literature regarding gene and diet interactions for disease risk profile is still poor.
The most intensively studied loci are those related to cardiovascular disease risk such as lipase and apolipoproteins gene variants [40] [41] [42] . The polymorphisms in these genes determined plasma lipid responses to dietary intake. Other gene variants like those corresponding to cholesterol ester transfer protein (CETP) and fatty-acid binding protein-2 (FABP2) are starting to show indications of significant effects towards disease risk [43] . Specifically, the Ala54 Thr FABP2 variant appears to be associated with insulin sensitivity, only in individuals consuming a high-fat diet. A recent paper reported that postpandrial lipemia (higher chylomicron cholesterol after olive oil only)in subjects with the Thr 54 variant of the FABP2 is dependent on the type of fat ingested [44] .
Few attempts were conducted to examine the influence of gene-diet interactions on obesity-related phenotypes. Using case-control designs, Nieters et al [45] showed that allelic variants of leptin and tumor necrosis factor α (TNFα) may affect obesity risk depending on the levels of intake of n-6 fatty acids. While, Martinez et al [36] found a significant interaction between obesity risk and high levels of carbohydrates consumption (above 49 % of total energy) for subjects carriers of the Glu allele of the ADRB2. Interestingly, a set of research papers have been devoted to the interplay of the polymorphism Pro12 Ala of the PPARG2 gene and dietary patterns in regard to obesity phenotypes (Table 1) . In vivo ligands for PPARG2 are thought to include a variety of fatty acids according to their chain length or degree of saturation. Luan et al [46] reported an inverse interaction between dietary polyunsaturated fat to saturated fat ratio (P:S ratio) with BMI among 12 Ala carriers. The mean BMI in Ala carriers is greater than in Pro/Pro homozygotes when P:S ratio is low. Memisoglu et al [47] in a largersize women population indicated the presence of associations between intake of total fat and BMI in regard to PPARG2 genotypes. They observed a significant trend between total fat intake and BMI, but only in Pro/Pro individuals [47] . However, intake of saturated fat was directly associated to increased BMI in carriers and non-carrier of the 12Ala variant, and intake of monounsaturated fat was inversely associated with BMI only in 12 Ala carriers of the PPARG2 polymorphism [48] .
In a case-control design, Nieters at al [45] observed a higher risk of obesity for carriers of the Ala 12 variant with increasing intake of arachidonic acid, whereas Marti et al [36] reported an increased obesity risk for carriers of the 12 Ala allele when consuming more than 49% of total energy from carbohydrates.
Other approach to demonstrate the mutual interactions between the genetic background and dietary patterns have consisted in the nutritional intervention on obese subjects designed to lose weight, whose outcome have been dependent on the occurrence of some polymorphism in candidate gene. Positive evidences of this interplay have been obtained for the Trp64Arg polymorphism affecting the β3 adrenergic receptor gene [49, 50] and for other gene polymorphisms such as those concerning the serotonin receptor [51] , PPARγ2 [48, 52] , leptin receptor [53] , UCPs [54] , in which the weight reduction was influenced by the genetic make up [55, 56] .
Summary
Obesity is a major chronic disease of multifactorial origin, which is dependent of modifiable (lifestyle) and uncontrollable risk factors (genes, age, family history, etc)
affecting the phenotype outcome [57, 58] . Considerable research now indicates that genetics is a factor in determining the individuals risk to obesity and at least 430 genes or chromosomal markers have been identified to be putatively involved in body weight regulation [2] . Furthermore, diet and genetics interact in numerous ways and mechanisms to influence obesity onset (appetite, energy expenditure, adipogenesis, etc).
Indeed, genetics influences the human body's physiological response, while diet influences the expression of genes related to energy homeostasis [57] .
The discrepancy among studies may reflect the difficulty of accurate measurements of specific types of dietary macro and micronutrients as well on the phenotype assessment rather than a discrepancy with biological relevance. Moreover, the different observations suggest that at least dietary counselling may need to be taken into consideration concerning the PPARG2 genotype. Identification of individuals who are genetically more likely to respond to particular dietary changes may be important for successful intervention in obesity treatment, since gene screening will allow health professionals to tailor-design and selective dietary counselling in individuals with genetic predisposition to be obese [59] . 
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